Skip to main content

Biocat has just announced the investment data for 2020 in the BioRegion Report, which shows an all-time record: healthcare startups in Catalonia raised €226 million in investment, more than ever before and twice as much as two years ago, fueled mainly by private capital.

Since 2016, life sciences startups in Catalonia have consistently raised over €100 million per year. This upward trend, along with the evolution in comparable European countries like Belgium and Sweden, begs the question of whether the BioRegion would be able to raise €500 million in investment by 2025.

To look closer at this ambitious goal, we’ve developed the analysis The BioRegion of Catalonia: road to €500M in investment per year, which poses questions about the possibility of scaling up the ecosystem and goes over their answers. 

With this as the starting point...


Figure 1. Source: Crunchbase. Analysis: Biocat. All operations ≥ $1M were considered. *Belgium without Galapagos ($5,100M)

 

...and this the evolution of private investment in recent years, 

 

Figure 2. Source: Crunchbase, Analysis: Biocat. Only includes seed, crowdequity and series A operations from $1M to $50M.

 

We asked ourselves: Is it possible to multiply investment and scale up?

Figure 3. Source: Crunchbase. Analysis: Biocat. All operations ≥ $1M were considered. *Belgium without Galapagos ($5,100M)

 

Need more information?

Contact our team

Contact us
silvia labe 2
Silvia LabéDirector of Marketing, Communications and Competitive Intelligence Departmentslabe@biocat.cat
Laura Diéguez
Laura DiéguezHead of Media Relations and Content(+34) 606 81 63 80ldieguez@biocat.cat
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.